Ownership history in Spire Wealth Management · 6 quarters on record
This page tracks every 13F SEC filing in which Spire Wealth Management reported a position in MADRIGAL PHARMACEUTICALS INC (MDGL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 100 | -150 | -60.0% | 0.00% | $46K | $458.66 |
| 2025 Q2 | ADDED | 250 | +150 | +150.0% | 0.00% | $76K | $302.64 |
| 2025 Q1 | UNCHANGED | 100 | — | 0% | 0.00% | $33K | $331.23 |
| 2024 Q4 | UNCHANGED | 100 | — | 0% | 0.00% | $31K | $308.57 |
| 2024 Q3 | UNCHANGED | 100 | — | 0% | 0.00% | $21K | $212.22 |
| 2024 Q2 | INITIATED | 100 | — | — | 0.00% | $28K | — |
As of 2025 Q4 — sorted by position size